Similarly, DKK3 promoter was methylated in 21 of 49 tumors (42.86%), including four AII (44.44%), four AIII (36.36%), and thirteen GBM (44.83%), respectively (Figure 3B,C). This evidence concerns the gene DKK3 and glioblastoma.